MPLT
Maplight Therapeutics
$7.98
−$0.19 (−2.33%)Oct 28, 2026
Key metrics
The numbers that frame MPLT today
- Market cap
- $370.10M
- ROIC
- -74.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $7.46
- 52wk High
- $40.43
Growth
Revenue and earnings trend for MPLT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MPLT
Is Maplight Therapeutics a good buy?
No. Maplight Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. We think Maplight Therapeutics is selling at a very high price.
What is the market capitalization of MPLT?
Maplight Therapeutics's market capitalization is $370.10M.
What is the 52-week high for MPLT stock?
The 52-week high for Maplight Therapeutics is $40.43. The current close of $7.98 is 80.3% below that high.
What is the 52-week low for MPLT stock?
The 52-week low for Maplight Therapeutics is $7.46. The current close of $7.98 is 7% above that low.
Does MPLT stock pay dividends?
Maplight Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MPLT?
Maplight Therapeutics's Debt / Equity ratio is 0.01.